2. Infection

Infection

Infection

Related Products

PDF 70.44 MB

Infection is a pathophysiological process that involves the invasion and colonization of a living organism (host) by disease-causing infectious agents, the reaction of host tissues to these agents and the toxins they produce, and the transmission of infectious agents to other hosts. Common infectious agents include viruses, viroids, prions, bacteria, nematodes, arthropods, and other macroparasites such as tapeworms. Hosts can fight infections using their immune system. Mammals often engage both innate and adaptive immune systems to eliminate infectious agents or inhibit their growth and transmission. When infection occurs, anti-infective drugs can suppress the infection. Several broad types of anti-infective drugs exist, depending on the type of organism targeted; they include antibacterial (antibiotic), antiviral, antifungal and antiparasitic agents.

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-N14336
    Halomicin D 56413-94-6 98%
    Halomicin D is an ansamycin antibiotic. Halomicin A has activity against Gram-positive and Gram-negative bacteria (individual).
    Halomicin D
  • HY-N14338
    Sannamycin L 83946-32-1 98%
    Sannamycin L is an aminoglycoside antibiotic. Sannamycin L has weak antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.
    Sannamycin L
  • HY-N1433R
    Phytolaccagenin (Standard) 1802-12-6
    Phytolaccagenin (Standard) is the analytical standard of Phytolaccagenin. This product is intended for research and analytical applications. Phytolaccagenin, a triterpenoid saponin, is the active component of Radix Phytolaccae. Phytolcaccagenin has antifungal activity, anti-inflammatory activity and lower toxicity
    Phytolaccagenin (Standard)
  • HY-N14341
    Mannosyl glucosaminide 14510-04-4 98%
    Mannosyl glucosaminide is an aminoglycoside antibiotic. Mannosyl glucosaminide has anti-bacterium, mycobacterium and beer yeast effects.
    Mannosyl glucosaminide
  • HY-N14342
    Manumycin E 156250-43-0 98%
    Manumycin E has anti-Gram-positive bacteria and Escherichia coli effects, but the effect is very weak against other anti-Gram-negative bacteria, and has no effect on fungi. Manumycin E inhibits RAS Faraday base transfer and has weak cytotoxic activity against human cloned cancer cell lines HCT-116 (IC50 is 15.6 μg/mL).
    Manumycin E
  • HY-N14343
    Manumycin F 156317-47-4 98%
    Manumycin F has anti-Gram-positive bacteria and Escherichia coli effects, but the effect is very weak against other anti-Gram-negative bacteria, and has no effect on fungi. Manumycin F inhibits RAS Faraday base transfer and has weak cytotoxic activity against human cloned cancer cell lines HCT-116 (IC50 is 15.6 μg/mL).
    Manumycin F
  • HY-N14344
    Manumycin G 156250-44-1 98%
    Manumycin G has anti-Gram-positive bacteria and Escherichia coli effects, but the effect is very weak against other anti-Gram-negative bacteria, and has no effect on fungi. Manumycin G inhibits RAS Faraday base transfer and has weak cytotoxic activity against human cloned cancer cell lines HCT-116 (IC50 is 15.6 μg/mL).
    Manumycin G
  • HY-N14346
    Ochracenomicin B 164177-48-4 98%
    Ochracenomicin B is found in the strain of Amicolatopsis sp. MJ 950-891. Ochracenomicin B has no antibacterial effect.
    Ochracenomicin B
  • HY-N14347
    Ochracenomicin C 164177-47-3 98%
    Ochracenomicin C is found in the strain of Amicolatopsis sp. MJ 950-891. Ochracenomicin C has a weak antibacterial effect.
    Ochracenomicin C
  • HY-N14359
    Megovalicin B 89759-26-2 98%
    Megovalicin B has the effect against subtilis and E.coli.
    Megovalicin B
  • HY-N14360
    Megovalicin H 115932-37-1 98%
    Megovalicin H has an effect against subtilis and E.coli, and it also has the effect against Pseudomonas aeruginosa.
    Megovalicin H
  • HY-N14362
    1-Hydroxycrisamicin A 204198-17-4 98%
    1-Hydroxycrisamicin A has anti-Gram-positive bacteria activity with a MIC of 0.78-3.12 μg/mL.
    1-Hydroxycrisamicin A
  • HY-N14364
    Flavipucine 38473-18-6 98%
    Flavipucine (Flavipucin), a glutarimide antibiotic, is found in the strain of Aspergillus flavipes F-2090/7. Flavipucine has antibacterial activity against B. subtilis. Flavipucine has antiprotozoal activity. Flavipucine has cytotoxic activity against several cancer cells.
    Flavipucine
  • HY-N14365
    Sannamycin J 83997-42-6 98%
    Sannamycin J is an aminoglycoside antibiotic. Sannamycin J can be found in Streptomyces sannanensis sp. KC-7038. Sannamycin J has weak antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.
    Sannamycin J
  • HY-N14367
    Fluoropolyoxin L 50355-67-4 98%
    Fluoropolyoxin L has the inhibitory activity of Escherichia coli and Streptococcus faecalis.
    Fluoropolyoxin L
  • HY-N14369
    9-Hydroxycrisamicin 194851-54-2 98%
    9-Hydroxycrisamicin has weak anti-Gram-positive bacteria activity, MIC is 6.25-25 μg/mL. 9-Hydroxycrisamicin has a strong growth inhibitory effect on human tumor cell lines.
    9-Hydroxycrisamicin
  • HY-N14370
    Menoxymycin A 160492-65-9 98%
    Menoxymycin A is an antibiotic. Menoxymycin A has a cytotoxic effect. Menoxymycin A inhibits KB and N18-RE-105 cells with IC50s of 0.86 μM and 0.14 μM.
    Menoxymycin A
  • HY-N14371
    Menoxymycin B 160523-76-2 98%
    Menoxymycin B is an antibiotic. Menoxymycin B has a cytotoxic effect. Menoxymycin B inhibits KB and N18-RE-105 cells with IC50s of 0.22 μM and 0.023 μM.
    Menoxymycin B
  • HY-N14374
    Mycoplanecin B 81018-84-0 98%
    Mycoplanecin B is a cyclic peptide antibiotic.
    Mycoplanecin B
  • HY-N14375
    Mycoplanecin C 81018-83-9 98%
    Mycoplanecin C is a cyclic peptide compound .
    Mycoplanecin C
Cat. No. Product Name / Synonyms Application Reactivity